Clinical research will now return to previous COVID Orange restrictions: review and scheduling of research visits for Groups 1-4 and 5b. This change is effective Monday, January 25, for studies that have already been approved to resume research activity through the CU Anschutz Medical Campus research restart portal or the UCHealth restart process.
We now have the ability to add interpreters on-demand to virtual visits through a vendor, Stratus Video, for more than 150 different languages by audio or video. This will greatly expand access to care for many patients with Limited English Proficiency. This capability is live now, and the Virtual Health Team has provided guidance through tip sheets.
The U.S. Food and Drug Administration (FDA) updated the Device Shortage List on the web page that lists Medical Device Shortages During the COVID-19 Public Health Emergency.
The FDA will be holding a public meeting to gather input on the scientific and ethical issues that surround the inclusion of pregnant women in clinical trials for drug development. The meeting will be held on 2/2/21 from 10am-2pm and 2/3/21 from 10am-1pm.
The Trial Innovation Network (TIN) is a collaborative national network within the CTSA Program to support innovation in multi-center clinical trials and studies.